Enteric infections and diagnostic testing

Current Opinion in Gastroenterology

Volumn 25, Issue 1, 2009, Pages 1-7

  Bennett Jr , William E ^a   Tarr, Phillip I ^a,b  

^a WASHINGTON UNIVERSITY   (United States)

^b Department of Pediatrics and Molecular Microbiology ^*

Author keywords

Bacteria; Diagnosis; Parasite; Pathogen; Stool

Indexed keywords

ACUTE ABDOMEN; ACUTE APPENDICITIS; ACUTE DIARRHEA; BACTERIUM IDENTIFICATION; BLOOD CHEMISTRY; BLOOD CULTURE; BLOODY DIARRHEA; CAMPYLOBACTER COLI; CHRONIC DIARRHEA; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL LABORATORY; CLINICAL PRACTICE; CLOSTRIDIUM DIFFICILE; COLON PERFORATION; CONSULTATION; CULTURE TECHNIQUE; DEVELOPING COUNTRY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE DURATION; ESCHERICHIA COLI O157; ESOPHAGITIS; ESOPHAGUS BIOPSY; FECES ANALYSIS; FECES CULTURE; HUMAN; IMMUNOASSAY; IMMUNOCOMPROMISED PATIENT; INTESTINE INFECTION; PARASITE IDENTIFICATION; PATHOGENESIS; PERSISTENT INFECTION; POLYMERASE CHAIN REACTION; REVIEW; SALMONELLA; SCREENING TEST; SHIGELLA; TRAVELLER DIARRHEA; URINALYSIS; VIRUS DETECTION;

BACTERIA; BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; GASTROINTESTINAL DISEASES; HUMANS; INTESTINAL MUCOSA;

EID: 58349087690     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32831ba094     Document Type: Review

References (66)

1. Bryce J, Boschi-Pinto C, Shibuya K, et al. WHO estimates of the causes of death in children. Lancet 2005; 365:1147-1152.
2. Herikstad H, Yang S, Van Gilder TJ, et al. A population-based estimate of the burden of diarrhoeal illness in the United States'. FoodNet, 1996-7. Epidemiol Infect 2002; 129:9-17.
3. Klein EJ, Boster OR, Stapp JR, et al. Diarrhea etiology in a Children's Hospital Emergency Department: a prospective cohort study. Clin Infect Dis 2006; 43:807-813.
4. Denno DM, Stapp JR, Boster DR, et al. Etiology of diarrhea in pediatric outpatient settings. Pediatr Infect Dis J 2005; 24:142-148.
5. Voetsch AC, Angulo FJ, Rabatsky-Ehr T, et al. Laboratory practices for stoolspecimen culture for bacterial pathogens, including Escherichia coli O157:H7, in the FoodNet sites, 1995-2000. Clin Infect Dis 2004; 38 ((Suppl 3)):S190-S197.
6. Cohen MB. Shiga toxin-producing E coli: two tests are better than one. J Pediatr 2002; 141:155-156.
7. Tarr P, Hecht G, Bass D. Bacterial, viral, and toxic causes of diarrhea, gastroenteritis, and anorectal infections. In: Yamada T, editor. Textbook of gastroenterology, 5th ed. Blackwell Publishing; 2008 (in press).
8. Ahn C, Holt NJ, Tarr PI. Shiga-toxin producing Escherichia coli and hemolytic uremic syndrome (HUS). In: Pollard AJ, editor. Hot topics in infection and immunity in children. Springer; 2008; 634 (in press).
9. Klein EJ, Stapp JR, Tarr PI, et al. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr 2002; 141:172-177.
10. Schumacher G, Sandstedt B, Mollby R, et al. Clinical and histologic features differentiating nonrelapsing colitis from first attacks of inflammatory bowel disease. Scand J Gastroenterol 1991; 26:151-161.
11. Schumacher G. First attack of inflammatory bowel disease and infectious colitis. A clinical, histological and microbiological study with special reference to early diagnosis. Scand J Gastroenterol Suppl 1993; 198: 1-24.
12. Schumacher G, Kollberg B, Sandstedt B, et al. A prospective study of first attacks of inflammatory bowel disease and nonrelapsing colitis. Microbiologic findings. Scand J Gastroenterol 1993; 28:1077-1085.
13. Schumacher G, Sandstedt B, Kollberg B. A prospective study of first attacks of inflammatory bowel disease and infectious colitis. Clinical findings and early diagnosis. Scand J Gastroenterol 1994; 29:265-274.
14. Bhutta ZA, Nelson EA, Lee WS, et al. Recent advances and evidence • gaps in persistent diarrhea. J Pediatr Gastroenterol Nutr 2008; 47:260-265. An excellent review of the current state of the diagnosis of diarrheal disease in children in resource-poor environments.
15. Salazar-Lindo E, Allen S, Brewster DR, et al. Intestinal infections and environmental enteropathy: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatotogy, and Nutrition. J Pediatr Gastroenterol Nutr 2004; 39 ((Suppl 2)):S662-S669.
16. Farthing MJ. Tropical malabsorption. Semin Gastrointest Dis 2002; 13:221 - 231.
17. Nath SK. Tropical sprue. Curr Gastroenterol Rep 2005; 7:343-349.
18. Steiner TS, Lima AA, Nataro JP, et al. Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J Infect Dis 1998; 177: 88-96.
19. Ricci KA, Girosi F, Tarr PI, et al. Reducing stunting among children: the potential contribution of diagnostics. Nature 2006; 444 (Suppl 1):29-38.
20. Kaplan JE, Gary GW, Baron RC, et al. Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med 1982; 96 (6 Pt 1):756-761.
21. Turcios RM, Widdowson MA, Sulka AC, et al. Reevaluation of epidemiological criteria for identifying outbreaks of acute gastroenteritis due to norovirus: United States, 1998-2000. Clin Infect Dis 2006; 42:964-969.
22. Duizer E, Pielaat A, Vennema H, et al. Probabilities in norovirus outbreak • diagnosis. J Clin Virol 2007; 40:38-42. A comparison of real time (RT)-PCR and EIA in the diagnosis of norovirus diarrhea, which shows a high rate of false positive results with EIA.
23. Hennessy TW, Marcus R, Deneen V, et al. Survey of physician diagnostic practices for patents with acute diarrhea: clinical and public health implications Clin Infect Dis 2004; 38 (Suppl 3):S203-S211.
24. Cohen MB, Nataro JP, Bernstein Dl, et al. Prevalence of diarrheagenic Escherichia coli in acute childhood enteritis: a prospective controlled study. J Pediatr 2005; 146:54-61.
25. Bender JB, Hedberg CW, Besser JM, et al. Surveillance by molecular subtype for Escherichia coli O157:H7 infections in Minnesota by molecular subtyping. N Engl J Med 1997; 337:388-394.
26. Ake JA, Jelacic S, Ciol MA, et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 2005; 115:e673-e680.
27. Marshall JA, Yuen LK, Catton MG, et al. Multiple outbreaks of Norwalk-Hke virus gastro-enteritis associated with a Mediterranean-style restaurant. J Med Microbiol 2001; 50:143-151.
28. Centers for Disease Control and Prevention (CDC). Importance of culture confirmation of Shiga toxin-producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis - New York and North Carolina, 2005. MMWR Morb Mortal Wkly Rep 2006; 55: 1042-1045.
29. Fey PD, Wicked RS, Rupp ME, et al. Prevalence of non-O157:H7 Shiga toxinproducing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 2000; 6:530-533.
30. Carroll KC, Adamson K, Korgenski K, et al. Comparison of a commercial reversed passive latex agglutination assay to an enzyme immunoassay for the detection of Shiga toxin-producing Escherichia coli. Eur J Clin Microbiol Infect Dis 2003; 22:689-692.
31. Park CH, Kim HJ, Hixon DL, et al. Evaluation of the Duopath verotoxin test for detection of Shiga toxins in cultures of human stools. J Clin Microbiol 2003; 41:2650-2653.
32. Manning SD, Madera RT, Schneider W, et al. Surveillance for Shiga toxinproducing Escherichia coli, Michigan, 2001-2005. Emerg Infect Dis 2007; 13:318-321.
33. Bartlett JG. Antibiotic-associated diarrhea. N Engl J Med 2002; 346:334-339.
34. Musher DM, Mannas A, Jain P, et al. Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay. J Clin Microbiol 2007; 45:2737-2739.
35. Sloan LM, Duresko BJ, Gustafson DR, et al. Comparison of real-time PCR •• for detection of the tcdC gene with four toxin immunoassays and culture in diagnosis of Clostridium difficile infection. J Clin Microbiol 2008; 46:1996-2001. A study of a new real-time PCR stool assay to detect C. difficile toxin genes, which shows equivalent sensitivity and specificity when compared with the gold standard of culture-based algorithm, and demonstrates the complexity of this field.
36. Borek AP, Aird DZ, Carroll KC. Frequency of sample submission for optimal utilization of the cell culture cytotoxicity assay for detection of Clostridium difficile toxin. J Clin Microbiol 2005; 43:2994-2995.
37. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium • difficile infection. Clin Infect Dis 2008; 46 ((Suppl 1)):S12-S18. An analysis of adjunct clinical modalities in the diagnosis of C. difficile infection, with emphasis on endoscopy, CT, Wood counts, and serum albumin levels. This article portrays the necessity to rethink the approach to this resurging issue.
38. Delmee M, Van Broeck J, Simon A, et al. Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J Med Microbiol 2005; 54 (Pt 2):187-191.
39. Ticehurst JR, Aird DZ, Dam LM, et al. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 2006; 44:1145-1149.
40. Reller ME, Lema CA, Perl TM, et al. Yield of stool culture with isolate • toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol 2007; 45:3601 - 3605. This is another approach that demonstrates the need for broad-minded assessment of all algorithms to detect C. difficile.
41. Fenner L, Widmer AF, Goy G, et al. Rapid and reliable diagnostic algorithm • for detection of Clostridium difficile. J Clin Microbiol 2008; 46:328-330. An algorithm, combining clinical criteria and EIA for C. difficile glutamate dehydrogenase, proves superior to traditional cytotoxicity assays.
42. Gray JJ, Kohli E, Ruggeri FM, et al. European multicenter evaluation of commercial enzyme immunoassays for detecting norovirus antigen in fecal samples. Clin Vaccine Immunol 2007; 14:1349-1355.
43. Weitzel T, Dittrich S, Möhl I, et al. Evaluation of seven commercial antigen detection tests for Giardia and Cryptosporidium in stool samples. Clin Microbiol Infect 2006; 12:656-659.
44. Rosenblatt JE. Clinical importance of adequately performed stool ova and parasite examinations. Clin Infect Dis 2006; 42:979-980.
45. Branda JA, Lin TY, Rosenberg ES, et al. A rational approach to the stool ova and parasite examination. Clin Infect Dis 2006; 42:972-978.
46. Furuno JP, Maguire JH, Green HP, et al. Clinical utility of multiple stool ova and parasite examinations in low-prevalence patient populations. Clin Infect Dis 2006; 43:795-796.
47. Pecson BM, Barrios JA, Johnson DR, et al. A real-time PCR method for quantifying viable ascaris eggs using the first internally transcribed spacer region of ribosomal DNA. Appl Environ Microbiol 2006; 72:7864-7872.
48. Verweij JJ, Brienen EA, Ziem J, et al. Simultaneous detection and quantification • of Ancylostoma duodenale, Necator americanus, and Oesophagostomum bifurcum in fecal samples using multiplex real-time PCR. Am J Trap Med Hyg 2007; 77:685-690. Study of a PCR-based approach to diagnosis of nondiarrheagenic helminthes that shows equivalent sensitivity to traditional microscopy, though this methodology is not yet widely available.
49. de Gruijter JM, van Lieshout L, Gasser RB, et al. Polymerase chain reactionbased differential diagnosis of Ancylostoma duodenale and Necator americanus infections in humans in northern Ghana. Trap Med Int Health 2005; 10:574-580.
50. Genta RM. Predictive value of an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of strongyloidiasis. Am J Clin Pathol 1988; 89:391-394.
51. Van Lieshout L Immunodiagnosis of Schistosomiasis mansoni in a low endemic area in Surinam by determination of the circulating antigens CAA and CCA. Acta Trap 1995; 59:19-29.
52. Legesse M, Erko B. Field-based evaluation of a reagent strip test for diagnosis • of Schistosomiasis mansoni by detecting circulating cathodic antigen (CCA) in urine in low endemic area in Ethiopia. Parasite 2008; 15:151-155. A study of a rapid urine antigen test for schistosomiasis is less sensitive than traditional stool microscopy but with improved speed and cost. An opportunity for the future, though the technology remains immature.
53. Gisbert JP, de la Morena F, Abraira V. Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and metaanalysis. Am J Gastroenterol 2006; 101:1921-1930.
54. Blanco S, Fornė M, Lacoma A, et al. Comparison of stool antigen immunoas- • say methods for detecting Helicobacter pylori infection before and after eradication treatment. Diagn Microbiol Infect Dis 2008; 61:150-155. A comparison between various commercially available stool antigen kits and the standard urea breath testing shows that some kits show equivalent sensitivity to urea breath testing. This study includes analysis of the newer immunochromatographic kits now available.
55. Cardenas VM, Dominguez DC, Puentes FA, et al. Evaluation of a novel stool •• native catalase antigen test for Helicobacter pylori infection in asymptomatic North American children. J Pediatr Gastroenterol Nutr 2008; 46:399-402. A study evaluating a new protein target for Helicobacter detection in stool.
56. Nakama H, Kamijo N, Fattah AS, Zhang B. Immunologic detection of fecal occult blood from upper digestive tract diseases. Hepatogastroenterology 1998;45:752-754.
57. Huicho L, Campos M, Rivera J, et al. Fecal screening tests in the approach to acute infectious diarrhea: a scientific overview. Pediatr Infect Dis J 1996; 15:486-494.
58. Puylaert JB. Imaging and intervention in patients with acute right lower quadrant disease. Baillieres Clin Gastroenterol 1995; 9:37-51.
59. Miller FH, Ma JJ, Scholz FJ. Imaging features of enterohemorrhagic Escherichia coli colitis. AJR Am J Roentgenol 2001; 177:619-623.
60. Wolff JH, Rubin A, Potter JD, et al. Clinical significance of colonoscopic findings associated with colonic thickening on computed tomography: is colonoscopy warranted when thickening is detected? J Clin Gastroenterol 2008; 42:472-475.
61. Su C, Brandt LJ, Sigal SH, et al. The immunohistological diagnosis of E. coli O157:H7 colitis: possible association with colonic ischemia. Am J Gastroenterol 1998; 93:1055-1059.
62. Sakellaris G, Tilemis S, Charissis G. Acute appendicitis in preschool-age children. Eur J Pediatr 2005; 164:80-83.
63. Nussinovitch M, Shapiro RP, Cohen AH, et al. Shigellosis complicated by perforated appendix. Pediatr Infect Dis J 1993; 12:352-353.
64. Hashimoto H, Mizukoshi K, Nishi M, et al. Epidemic of gastrointestinal tract infection including hemorrhagic colitis attributable to Shiga toxin 1 -producing Escherichia coli O118:H2 at a junior high school in Japan. Pediatrics 1999; 103:e2.
65. Kravitz GR, Smith K, Wagstrom L. Colonic necrosis and perforation secondary to Escherichia coli O157:H7 gastroenteritis in an adult patient without hemolytic uremic syndrome. Clin Infect Dis 2002; 35:e103-e105.
66. Helms M, Simonsen J, Molbak K. Foodborne bacterial infection and hospitalization: a registry-based study. Clin Infect Dis 2006; 42:498-506.